iconstar paper   Hepatitis C Articles (HCV)  
Back grey arrow rt.gif
 
 
HCV & HCV/HIV Coinfection Micro-Elimination Grants: funding for 30+ projects -
 
  20 September 2018 & 20 August 2018: LOI submission window closes
 
The World Health Organization has established a goal of eliminating viral hepatitis (hepatitis B and hepatitis C) by the year 2030.
 
In support of this target, Gilead's Medical Affairs team has created the CHIME Program (Conquering Hepatitis via Micro-Elimination), offering research grant funding for up to 30 hepatitis C virus (HCV) projects which focus on breaking down national and international HCV elimination goals into micro-elimination projects among smaller and more defined populations.
 
Gilead will support projects with research grants of up to $350,000 each, with an emphasis on achieving geographic distribution across the globe. Successful proposals will demonstrate clear scientific objectives, defined timelines, a comprehensive operational plan and the potential to generate data that has relevance to the medical community and policy makers.......http://www.gilead.com/research/conquering-hepatitis-via-micro-elimination For World Hepatitis Day (July 28), learn more about the different ways to help eliminate hepatitis C through Call for Application Investigator-Sponsored Research Programs at Gilead Sciences.
 
Relaunching in 2018 - now accepting applications!
 
HIV/HCV No Co-infection (NoCo) Program
.....Gilead will support projects with research grants of up to $600,000 each, with an emphasis on achieving geographic distribution across the globe....20 August 2018: LOI submission window closes
 
This program intends to support investigators focused on addressing the challenges associated with HCV elimination for individuals co-infected with HIV or in people at high risk for HIV infection, ie, HIV-negative men who have sex with men on pre-exposure prophylaxis (PrEP). Many people living with HIV or on PrEP are linked and engaged in care. Thus, targeting micro-elimination of HCV in HIV-infected or high-risk HIV-uninfected individuals is a feasible and a more proximate short-term goal and a positive step toward more global HCV elimination. For more information: http://www.gilead.com/research/noco-2018-elimination-program (NoCo@gilead.com).
 
Continuing to accept applications!
 
Conquering Hepatitis vIa Micro-Elimination (CHIME) Program

 
This program is offering research grant funding for up to 30 HCV projects which focus on breaking down national and international HCV elimination goals into micro-elimination projects among smaller and more defined populations. For more information: http://www.gilead.com/research/conquering-hepatitis-via-micro-elimination (CHIME@gilead.com).

HepC

 
 
 
 
  iconpaperstack View Older Articles   Back to Top   www.natap.org